Hilden, Germany, and Germantown, Maryland, October 29, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of three innovative Sample to Insight workflows for next-generation sequencing (NGS) research in oncology using QIAGEN’s GeneReader NGS System and other NGS platforms. QIAGEN is introducing the novel NGS workflows …
Tag Archives: Qiagen
October, 2018
January, 2018
-
25 January
FDA Approves First-Ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms
Hilden, Germany, and Germantown, Maryland, January 23, 2018 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has received clearance for its ipsogen JAK2 RGQ PCR Kit (ipsogen JAK2 assay) from the U.S. Food and Drug Administration (FDA) for additional use in the diagnosis of all myeloproliferative neoplasms (MPNs), which are …
-
19 January
QIAGEN Receives FDA Approval to Expand Use of EGFR Test in Non-Small Cell Lung Cancer
Germantown, Maryland, and Hilden, Germany, January 18, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has approved a PMA supplement extending the indications for use of QIAGEN’s therascreen® EGFR RGQ PCR Kit as a companion diagnostic to guide the use …
February, 2016
-
12 February
10x Genomics Collaborates with Qiagen for Sequencing and Single Cell Analysis Workflows
PLEASANTON, Calif.–(BUSINESS WIRE)–10x Genomics, Inc. today announced the establishment of a co-marketing and co-development collaboration with QIAGEN N.V. for the co-promotion and co-development of integrated workflow solutions for nucleic acid sequencing and single cell analysis. “We welcome the opportunity to partner with QIAGEN, with their comprehensive offerings for genomic analysis, …